Sbir phase II: transcranial dynamic focused ultrasound for the non-invasive opening of the blood-brain barrier (BBB)

Ended Cooperative Agreement Awarded Last action

Award ID
2111810
Recipient
Awarding agency
Obligated
$998,501

Award facts

Assistance listing
47.041 Engineering
Completion date
Place of performance
Mountain View, CA 94043, USA

Award details come from USAspending.gov.

About this award

Cordance Medical Inc. received a $998,501 cooperative agreement award from the National Science Foundation under the Engineering program (CFDA 47.041) for the period of July 15, 2021 through June 30, 2023. The award will support Cordance Medical's efforts to develop transcranial dynamic focused ultrasound for the non-invasive opening of the blood-brain barrier, allowing targeted delivery of therapeutic agents to the brain. The Engineering program seeks to improve quality of life and economic strength through engineering research and education innovation. This award advances those goals by funding Cordance Medical's work to establish a novel non-invasive method for targeted drug delivery to the brain, which if successful could lead to new treatment options for various neurological disorders.

Quick answers

Who received award 2111810?

2111810 was awarded to Cordance Medical Inc. by Division of Industrial Innovation (National Science Foundation) on July 15, 2021.

How much is award 2111810 worth?

$998,501 has been obligated on 2111810.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award